Biosimilars

In recent years, biological therapies have become increasingly used for the treatment of many conditions, specially inflammatory diseases. But they are expensive. Very expensive. To the rescue come the next generation of drugs: biosimilars. They are biologic medical products almost identical to the original product, but manufactured by a different company. The war of misinformation is served. How clinically relevant is the fact that almost identical is no really identical? The fear of the new is keeping thousands of patients away from very effective and safe therapies, and making some companies millions.

More
Less

Play via Art Stream

Art Stream subscribers add this and any any other artwork that is not sold out to their playlists. Start Free Trial

Your purchase includes

High resolution image
Your edition number
Your certificate of authenticity
Right to resell on Trade

Enjoy your digital edition on any device and connected screen, using a web-browser or from the Sedition app.

Sample Certificate

Every edition is personalised, signed and numbered with a Certificate of Authenticity

24h Private View Is Live

New collection Digital Decade SE by Designcollector Network is available.

Time Remaining